Clinical Trial Update: Safety and Immunogenicity of Chiron's Investigational H. Pylori Vaccine in Healthy Adults [Phase 1]

View source ↗

Summary

Phase 1 study reports safety and immunogenicity data for an investigational Helicobacter pylori vaccine in healthy adults.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastric Cancer
• Gastritis
• Helicobacter Pylori Infection
• Malt Lymphoma
• Peptic Ulcer Disease

Drugs mentioned

• H. pylori vaccine (investigational)

Snippet

Sponsor: Novartis Vaccines | Conditions: Helicobacter Pylori, Gastritis | Phase 1 | Status: COMPLETED